NASDAQ:SNES SenesTech - SNES Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding SenesTech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $1.52 +0.19 (+14.29%) (As of 03/29/2023 12:00 AM ET) Add Compare Share Share Today's Range$1.35▼$1.6950-Day Range$1.33▼$4.4552-Week Range$1.31▼$16.00Volume211,272 shsAverage Volume188,566 shsMarket Capitalization$3.12 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About SenesTech (NASDAQ:SNES) StockSenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. It offers its ContraPest product to residential, and commercial sectors such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Phoenix, AZ.Read More Receive SNES Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SenesTech and its competitors with MarketBeat's FREE daily newsletter. Email Address SNES Stock News HeadlinesMarch 29, 2023 | finance.yahoo.comTIME Magazine Takes a Closer Look at ContraPest as a Solution to Global Rat InfestationsMarch 22, 2023 | americanbankingnews.comStockNews.com Initiates Coverage on SenesTech (NASDAQ:SNES)March 29, 2023 | Porter & Company (Ad)Biden's corruption knows no endPorter Stansberry here -- I reveal the shocking changes this Obama policy will usher in… what it means for you, your family, and your finances… and how you can prepare for this new American era. Stream my new documentary at no cost today.March 20, 2023 | finance.yahoo.comSenesTech, Inc. (NASDAQ:SNES) Q4 2022 Earnings Call TranscriptMarch 16, 2023 | finance.yahoo.comSenesTech Announces 2022 Financial ResultsMarch 14, 2023 | finance.yahoo.comSenesTech Working with TriptoBIO on Biosynthetic TriptolideMarch 8, 2023 | finance.yahoo.comSenesTech to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Thursday, March 16, 2023February 28, 2023 | finance.yahoo.comContraPest® Success Stories Reported at Vertebrate Pest ConferenceMarch 29, 2023 | Investor Place Media (Ad)Biden To Unleash "Choke Point" Operation On America?Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.February 25, 2023 | latimes.comUniversal’s Super Nintendo World is the play-focused theme park land for our timesFebruary 16, 2023 | finance.yahoo.comSenesTech Names Nicole Williams as Chief Revenue OfficerFebruary 6, 2023 | finance.yahoo.comContraPest® Approved for General Use in New York StateFebruary 1, 2023 | finance.yahoo.comSenesTech, Inc. (SNES) Stock Historical Prices & Data - Yahoo FinanceJanuary 24, 2023 | finance.yahoo.comSenesTech to Participate in the Lytham Partners Investor Select ConferenceDecember 20, 2022 | finance.yahoo.comSenesTech Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 15, 2022 | finance.yahoo.comContraPest® Deploying in City of Los AngelesNovember 18, 2022 | finance.yahoo.comSenesTech, Inc. Announces Closing of $5 Million Public OfferingNovember 16, 2022 | finance.yahoo.comSenesTech Third Quarter 2022 Earnings: Misses ExpectationsNovember 16, 2022 | finance.yahoo.comSenesTech, Inc. Announces Pricing of $5 Million Public OfferingNovember 15, 2022 | finance.yahoo.comSenesTech Announces Reverse Stock SplitNovember 14, 2022 | finance.yahoo.comSenesTech Announces Appointment of Vector and Pest Control Industry Veteran Joel Fruendt as Chief Executive OfficerNovember 14, 2022 | finance.yahoo.comSenesTech Announces Third Quarter 2022 Financial ResultsNovember 14, 2022 | finance.yahoo.comSenestech, Inc. (SNES) Reports Q3 Loss, Misses Revenue EstimatesNovember 9, 2022 | finance.yahoo.comSenesTech to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022November 6, 2022 | reuters.comSNES.O - SenesTech Inc | Stock Price & Latest News | ReutersOctober 20, 2022 | msn.comU.S. shares lower at close of trade; Dow Jones Industrial Average down 0.33% - msnNOWOctober 19, 2022 | investing.comU.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.33% By Investing.com - Investing.comSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SNES Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SenesTech and its competitors with MarketBeat's FREE daily newsletter. Email Address SNES Company Calendar Last Earnings11/10/2021Today3/29/2023Next Earnings (Estimated)5/11/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Agricultural chemicals Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SNES CUSIPN/A CIK1680378 Webwww.senestech.com Phone(928) 779-4143FaxN/AEmployees26Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($16.60) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,690,000.00 Net Margins-951.42% Pretax Margin-951.42% Return on Equity-177.67% Return on Assets-137.16% Debt Debt-to-Equity RatioN/A Current Ratio4.62 Quick Ratio3.98 Sales & Book Value Annual Sales$1.02 million Price / Sales3.05 Cash FlowN/A Price / Cash FlowN/A Book Value$6.52 per share Price / Book0.23Miscellaneous Outstanding Shares2,050,000Free Float1,809,000Market Cap$3.12 million OptionableNot Optionable Beta1.15 Key ExecutivesJoel L. FruendtChief Executive Officer & DirectorKim WolinExecutive VP-Operations & Human ResourcesThomas C. ChestermanCFO, Secretary, Treasurer & Executive VPBrandy PyzynaVice President-Research & Regulatory AffairsDan PalaskyChief Technical OfficerKey CompetitorsSintx TechnologiesNASDAQ:SINTDermata TherapeuticsNASDAQ:DRMARubius TherapeuticsNASDAQ:RUBYStatera BiopharmaNASDAQ:STABTenax TherapeuticsNASDAQ:TENXView All CompetitorsInstitutional OwnershipArmistice Capital LLCBought 72,130 shares on 2/15/2023Ownership: 11.825%View All Institutional Transactions SNES Stock - Frequently Asked Questions Should I buy or sell SenesTech stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SenesTech in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" SNES shares. View SNES analyst ratings or view top-rated stocks. How have SNES shares performed in 2023? SenesTech's stock was trading at $3.09 on January 1st, 2023. Since then, SNES stock has decreased by 50.8% and is now trading at $1.52. View the best growth stocks for 2023 here. When is SenesTech's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023. View our SNES earnings forecast. How were SenesTech's earnings last quarter? SenesTech, Inc. (NASDAQ:SNES) released its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.09) EPS for the quarter, hitting the consensus estimate of ($0.09). The business earned $0.18 million during the quarter, compared to the consensus estimate of $0.22 million. SenesTech had a negative net margin of 951.42% and a negative trailing twelve-month return on equity of 177.67%. During the same period in the prior year, the business earned ($0.28) EPS. When did SenesTech's stock split? SenesTech's stock split on Thursday, September 1st 2022. The 2-1 split was announced on Thursday, September 1st 2022. The newly issued shares were issued to shareholders after the market closes on Thursday, September 1st 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. What other stocks do shareholders of SenesTech own? Based on aggregate information from My MarketBeat watchlists, some companies that other SenesTech investors own include TransEnterix (TRXC), Carrizo Oil & Gas (CRZO), Auris Medical (EARS), Marathon Oil (MRO), Adamis Pharmaceuticals (ADMP), McDermott International (MDR), ZIOPHARM Oncology (ZIOP), Citius Pharmaceuticals (CTXR) and DURECT (DRRX). When did SenesTech IPO? (SNES) raised $15 million in an initial public offering on Thursday, December 8th 2016. The company issued 1,900,000 shares at $8.00 per share. Roth Capital Partners served as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager. What is SenesTech's stock symbol? SenesTech trades on the NASDAQ under the ticker symbol "SNES." Who are SenesTech's major shareholders? SenesTech's stock is owned by many different retail and institutional investors. Top institutional shareholders include Armistice Capital LLC (11.82%). View institutional ownership trends. How do I buy shares of SenesTech? Shares of SNES stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is SenesTech's stock price today? One share of SNES stock can currently be purchased for approximately $1.52. How much money does SenesTech make? SenesTech (NASDAQ:SNES) has a market capitalization of $3.12 million and generates $1.02 million in revenue each year. The company earns $-9,690,000.00 in net income (profit) each year or ($16.60) on an earnings per share basis. How can I contact SenesTech? SenesTech's mailing address is 23460 NORTH 19TH AVENUE SUITE 110, PHOENIX AZ, 85027. The official website for the company is www.senestech.com. The company can be reached via phone at (928) 779-4143 or via email at senestech@lythampartners.com. This page (NASDAQ:SNES) was last updated on 3/29/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.